Efficacy and safety of crisaborole ointment, 2%, in participants aged ≥45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase 2a study

Autor: Silverberg, Jonathan I., Kirsner, Robert S., Margolis, David J., Tharp, Michael, Myers, Daniela E., Annis, Karen, Graham, Daniela, Zang, Chuanbo, Vlahos, Bonnie L., Sanders, Paul
Zdroj: In Journal of the American Academy of Dermatology May 2024 90(5):945-952
Databáze: ScienceDirect
Externí odkaz: